Literature DB >> 35612781

Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment.

Chuwei Yu1,2, Jing Chen3,4, Jin Ren5,6.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common metabolic diseases and closely associated with lipid disorder. Mitochondrion has been recognized to play a key role in lipid metabolism as the main site of energy metabolism in cells, and its dysfunction is involved in the progression of NAFLD. MicroRNAs (miRNAs), one of regulators in the pathogenesis of NAFLD, are discovered to modulate mitochondrial function by targeting mitochondrial proteins or mitochondrial-related factors, thereby improving or deteriorating NAFLD-associated pathologies. This review summarizes the differentially expressed miRNAs from clinical and experimental models of NAFLD with abilities in regulating mitochondrial function, expounds their underlying molecular mechanism and discusses their prospect and future research direction.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Metabolic diseases; MiRNA; Mitochondrial dysfunction; Mitochondrion; NAFLD

Mesh:

Substances:

Year:  2022        PMID: 35612781     DOI: 10.1007/s11033-022-07503-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  74 in total

1.  Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats.

Authors:  Rachel J Perry; Dongyan Zhang; Xian-Man Zhang; James L Boyer; Gerald I Shulman
Journal:  Science       Date:  2015-02-26       Impact factor: 47.728

Review 2.  Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression.

Authors:  Mengfan Pu; Jing Chen; Zhouteng Tao; Lingling Miao; Xinming Qi; Yizheng Wang; Jin Ren
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

Review 3.  Mitochondria: one of the destinations of miRNAs.

Authors:  Lakshmi Sripada; Dhanendra Tomar; Rajesh Singh
Journal:  Mitochondrion       Date:  2012-10-17       Impact factor: 4.160

Review 4.  Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies.

Authors:  Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Trends Endocrinol Metab       Date:  2016-12-13       Impact factor: 12.015

Review 5.  MicroRNAs as regulators of mitochondrial dysfunction and obesity.

Authors:  Mora Murri; Hamid El Azzouzi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

Review 6.  Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell Metab       Date:  2017-08-31       Impact factor: 27.287

Review 7.  Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.

Authors:  Thomas G Cotter; Mary Rinella
Journal:  Gastroenterology       Date:  2020-02-13       Impact factor: 22.682

Review 8.  The Role of microRNAs in Mitochondria: Small Players Acting Wide.

Authors:  Filipe V Duarte; Carlos M Palmeira; Anabela P Rolo
Journal:  Genes (Basel)       Date:  2014-09-26       Impact factor: 4.096

Review 9.  Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

Authors:  Annieke C G van Baar; Suzanne Meiring; Frits Holleman; David Hopkins; Geltrude Mingrone; Jacques Devière; Max Nieuwdorp; Jacques J G H M Bergman
Journal:  Gut       Date:  2021-09-08       Impact factor: 23.059

Review 10.  Racial differences in prevalence and severity of non-alcoholic fatty liver disease.

Authors:  Maurizio Bonacini; Farah Kassamali; Swathi Kari; Nieves Lopez Barrera; Mohamed Kohla
Journal:  World J Hepatol       Date:  2021-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.